These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 18759346

  • 1. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.
    Ibrahim SM, Mulcahy MF, Lewandowski RJ, Sato KT, Ryu RK, Masterson EJ, Newman SB, Benson A, Omary RA, Salem R.
    Cancer; 2008 Oct 15; 113(8):2119-28. PubMed ID: 18759346
    [Abstract] [Full Text] [Related]

  • 2. Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option.
    Saxena A, Bester L, Chua TC, Chu FC, Morris DL.
    Ann Surg Oncol; 2010 Feb 15; 17(2):484-91. PubMed ID: 19876691
    [Abstract] [Full Text] [Related]

  • 3. Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization.
    Camacho JC, Kokabi N, Xing M, Prajapati HJ, El-Rayes B, Kim HS.
    J Vasc Interv Radiol; 2014 Feb 15; 25(2):256-65. PubMed ID: 24461131
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.
    Hoffmann RT, Paprottka PM, Schön A, Bamberg F, Haug A, Dürr EM, Rauch B, Trumm CT, Jakobs TF, Helmberger TK, Reiser MF, Kolligs FT.
    Cardiovasc Intervent Radiol; 2012 Feb 15; 35(1):105-16. PubMed ID: 21431970
    [Abstract] [Full Text] [Related]

  • 6. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.
    Salem R, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Ibrahim S, Atassi B, Baker T, Gates V, Miller FH, Sato KT, Wang E, Gupta R, Benson AB, Newman SB, Omary RA, Abecassis M, Kulik L.
    Gastroenterology; 2010 Jan 15; 138(1):52-64. PubMed ID: 19766639
    [Abstract] [Full Text] [Related]

  • 7. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres.
    Mulcahy MF, Lewandowski RJ, Ibrahim SM, Sato KT, Ryu RK, Atassi B, Newman S, Talamonti M, Omary RA, Benson A, Salem R.
    Cancer; 2009 May 01; 115(9):1849-58. PubMed ID: 19267416
    [Abstract] [Full Text] [Related]

  • 8. Radioembolization in patients with hepatic metastases from breast cancer.
    Jakobs TF, Hoffmann RT, Fischer T, Stemmler HJ, Tatsch K, La Fougere C, Murthy R, Reiser MF, Helmberger TK.
    J Vasc Interv Radiol; 2008 May 01; 19(5):683-90. PubMed ID: 18440456
    [Abstract] [Full Text] [Related]

  • 9. Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.
    Mouli S, Memon K, Baker T, Benson AB, Mulcahy MF, Gupta R, Ryu RK, Salem R, Lewandowski RJ.
    J Vasc Interv Radiol; 2013 Aug 01; 24(8):1227-34. PubMed ID: 23602420
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization.
    Gaba RC, Lewandowski RJ, Kulik LM, Riaz A, Ibrahim SM, Mulcahy MF, Ryu RK, Sato KT, Gates V, Abecassis MM, Omary RA, Baker TB, Salem R.
    Ann Surg Oncol; 2009 Jun 01; 16(6):1587-96. PubMed ID: 19357924
    [Abstract] [Full Text] [Related]

  • 12. Optimization of radioembolic effect with extended-shelf-life yttrium-90 microspheres: results from a pilot study.
    Lewandowski RJ, Riaz A, Ryu RK, Mulcahy MF, Sato KT, Kulik LM, Gates VL, Baker T, Omary R, Salem R.
    J Vasc Interv Radiol; 2009 Dec 01; 20(12):1557-63. PubMed ID: 19854068
    [Abstract] [Full Text] [Related]

  • 13. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases.
    Jakobs TF, Hoffmann RT, Dehm K, Trumm C, Stemmler HJ, Tatsch K, La Fougere C, Murthy R, Helmberger TK, Reiser MF.
    J Vasc Interv Radiol; 2008 Aug 01; 19(8):1187-95. PubMed ID: 18656012
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Impact of intraoperative radiotherapy (IORT) on survival of patients with unresectable hilar cholangiocarcinoma.
    Kaiser GM, Frühauf NR, Lang H, Sauerwein W, Sotiropoulos GC, Zöpf T, Grabellus F, Wittig A, Oldhafer KJ, Malagó M, Broelsch CE.
    Hepatogastroenterology; 2008 Aug 01; 55(88):1951-4. PubMed ID: 19260456
    [Abstract] [Full Text] [Related]

  • 16. Resin-based Yttrium-90 microspheres for unresectable and failed first-line chemotherapy intrahepatic cholangiocarcinoma: preliminary results.
    Jia Z, Paz-Fumagalli R, Frey G, Sella DM, McKinney JM, Wang W.
    J Cancer Res Clin Oncol; 2017 Mar 01; 143(3):481-489. PubMed ID: 27826686
    [Abstract] [Full Text] [Related]

  • 17. Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study.
    Gangi A, Shah J, Hatfield N, Smith J, Sweeney J, Choi J, El-Haddad G, Biebel B, Parikh N, Arslan B, Hoffe SE, Frakes JM, Springett GM, Anaya DA, Malafa M, Chen DT, Chen Y, Kim RD, Shridhar R, Kis B.
    J Vasc Interv Radiol; 2018 Aug 01; 29(8):1101-1108. PubMed ID: 30042074
    [Abstract] [Full Text] [Related]

  • 18. 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging.
    Lewandowski RJ, Thurston KG, Goin JE, Wong CY, Gates VL, Van Buskirk M, Geschwind JF, Salem R.
    J Vasc Interv Radiol; 2005 Dec 01; 16(12):1641-51. PubMed ID: 16371530
    [Abstract] [Full Text] [Related]

  • 19. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
    Zeng ZC, Tang ZY, Fan J, Zhou J, Qin LX, Ye SL, Sun HC, Wang BL, Li D, Wang JH, Zeng MS, Guo W, Tan YS.
    Cancer J; 2006 Dec 01; 12(2):113-22. PubMed ID: 16630402
    [Abstract] [Full Text] [Related]

  • 20. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.
    Kennedy AS, Dezarn WA, McNeillie P, Coldwell D, Nutting C, Carter D, Murthy R, Rose S, Warner RR, Liu D, Palmedo H, Overton C, Jones B, Salem R.
    Am J Clin Oncol; 2008 Jun 01; 31(3):271-9. PubMed ID: 18525307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.